4.0 Article

Accuracy of the Spacelabs 90217 ambulatory blood pressure monitor in a pediatric population

Journal

BLOOD PRESSURE MONITORING
Volume 20, Issue 5, Pages 295-298

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MBP.0000000000000132

Keywords

adolescents; ambulatory blood pressure monitoring; children; validation

Funding

  1. Case Western Reserve University/Cleveland Clinic CTSA Core Award [3UL1RR024989-03S2]
  2. National Institutes of Child Health and Human Development [5U10HD031324-15, 3U10 HD 021324-15S1, 5U10 HD 031323-15, U10 HD045934, U10 HD045986]
  3. Translational Research Institute through the NIH National Center for Research Resources [UL1TR000039, KL2TR000063]
  4. National Center for Advancing Translational Sciences
  5. Arkansas Children's Hospital Research Institute
  6. Arkansas Biosciences Institute

Ask authors/readers for more resources

BackgroundAmbulatory blood pressure monitoring techniques provide unique advantages for diagnosing hypertension, although few devices have been independently validated in the pediatric population.MethodsWe sought to validate the accuracy of ambulatory blood pressure monitoring with the Spacelabs 90217 monitor in children using a modified British Hypertension Society protocol.ResultsA total of 112 children, aged between 6 and 17 years, completed the study at one of the three participating centers. Overall, the monitor earned an A' for systolic blood pressure and B' for diastolic blood pressure. It performed slightly better among 6-12 year olds (A/A) compared with 13-17 year olds (A/B).ConclusionsWe conclude that the Spacelabs 90217 monitor is an appropriate monitor for use in children who are 6 years of age or older.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available